From 2 June till 6 June 2023: HIGHLIGHTS FROM ASCO – GYNAECO

Your direct line with Chicago

The American Society of Clinical Oncology (ASCO) 2023 brings together leading experts in the different fields of cancer from around the world. And, as usual, they gather together in Chicago, USA. The MediMix team is also onsite, and will – together with your Belgian colleagues – keep you posted about the hottest topics as they happen. And, we dive into posters and hot topics with the experts as they are being presented.

Stay tuned, and get ready for an exciting and informative journey!

With the educational support of:

Daily highlights in gynaeco

Highlight 4 in gynaecologic cancer

Prof Els Van Nieuwenhuysen discussed the initial efficacy and safety results from ENGOT-ov60/GOG-3052/RAMP 201: a phase 2 study of avutometinib with or without defactinib in recurrent low-grade serous ovarian cancer,

See video »

In-depth stories about gynaeco

Jean-François Baurain

DESTINY-PanTumor-02 study

Prof Jean-François Baurain, medical oncologist at Cliniques universitaires Saint-Luc, Brussels sheds his light on the interim results of the phase 2 trial DESTINY-PanTumor-02, a tumor-agnostic study including a range of

See video »

Z1. Researchpark 30, 1731 Zellik, Belgium
Website created by MediMix © 2023 - Privacy Policy